SOURCE: NaturalNano, Inc.

January 22, 2008 07:00 ET

NaturalNano to Present in New York City at Friedland Investment Undiscovered Equities Conference

ROCHESTER, NY--(Marketwire - January 22, 2008) - NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N), a developer of advanced nanomaterials and extended release nanotechnologies, today announced that President and Chief Technology Officer Cathy Fleischer, Ph.D. will present at the Friedland Investment Undiscovered Equities Conference in New York City at 12:15 p.m. EST, Wednesday, Jan. 23, 2008. The conference will be held at the DoubleTree Metropolitan Hotel.

Fleischer commented: "This conference is an opportunity for NaturalNano to showcase the industry-leading properties of our proprietary nanocomposite additive, Pleximer™, and the multiple advantages it holds for both manufacturers and consumers. In addition, bringing the financial community up to speed on the successful completion of our aggressive 2007 goals is a great way for us to continue building on our momentum toward commercialization of our products."

NaturalNano ( said it will also provide updates on its licensing deal with the Naval Research Laboratory (NRL), as well as on its overall strategy towards future product introduction.

About NaturalNano, Inc.

NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) is a materials science company focused on developing and commercializing advanced nanocomposites and extended release nanotechnologies. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer™ polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. For more information, visit

Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.

Contact Information